Searchable abstracts of presentations at key conferences in endocrinology

ea0077op6.1 | Endocrine Cancer and Late Effects | SFEBES2021

Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review

Garrahy Aoife , Tadman Mike , Slater Viv , Moore Niall , Coupe Nicholas , Weaver Andrew , Soonawalla Zahir , Patel Neel , May Christine , Jafar Mohammadi Bahram

Gallium68-Dotatate PET-CT is a somatostatin-receptor (SSTR) based imaging modality employed in the diagnosis and follow-up of Neuroendocrine Tumours (NET). We set out to investigate the incidence of incidental findings, some of which are related to SSTR expression, in our NET patient cohort in Oxford University Hospital. Sixty-eight patients underwent Gallium68-Dotatate PET-CT between June 2020 and June 2021. 40 patients (59%) were female, and median age ...